BOCA RATON, Fla., Nov. 14, 2025 /PRNewswire/ — BodyLogicMD, a leading provider of bioidentical hormone replacement therapy (BHRT), integrative medicine and weight loss treatment, announced it completely supports the recommendation to remove black box warnings on certain forms of estrogen used to treat menopause symptoms.
Data from an old government study on women’s health, known as the Women’s Health initiative (WHI), led to conclusions that hormone therapy was linked to an increased risk of several conditions, including breast cancer, heart disease and potentially dementia. The average age of women in the study was 63 years old, a decade beyond the age of most women wanting to start hormone therapy. Additionally, the hormone therapy used in the study was artificial and proven to be a substandard form of hormone therapy.
The black box warning was added to labels in 2003 by the Food and Drug Administration (FDA) to warn of potential health risks associated with estrogen hormone therapy.
“BodyLogicMD has over 20 years of science-based experience treating thousands of women suffering from menopause and perimenopause,” Jennifer Landa, M.D., BodyLogicMD Chief Medical Officer, said. “After extensive research and review of clinical data, experts have found that these risks are overstated and do not apply to all forms of estrogen. In fact, estrogen has been shown to reduce fractures, dementia, heart disease and death for any reason in women who start therapy in the first decade after menopause. The FDA black box warning has caused confusion among menopausal women and healthcare providers about the safety and efficacy of these menopause treatments. It has prevented many women from seeking treatment for their menopause symptoms such as hot flashes, mood swings and sleep disturbances. This decision is potentially life changing for women.”
For more information about BodyLogicMD and personalized menopause and perimenopause treatments, visit https://www.bodylogicmd.com.
About BodyLogicMD
Founded in 2003 and headquartered in Boca Raton, FL, BodyLogicMD physician-owned practices make up a network of highly trained practitioners specializing in bioidentical hormone replacement therapy (BHRT), integrative medicine and weight loss.
BodyLogicMD’s medically supervised treatment plans are for women and men suffering from hormonal imbalance and conditions of aging, such as menopause and andropause.
BodyLogicMD serves patients in 30 states. These states include Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, Missouri, New York, Nevada, New Jersey, North Carolina, Ohio, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, West Virginia and Wisconsin.
BodyLogicMD is a member of the American Academy of Anti-Aging Medicine (A4M) and requires all practitioners in the network to be trained and certified through the A4M Fellowship in Anti-Aging and Regenerative Medicine.
BodyLogicMD partners with leading laboratories, compounding pharmacies, and nutraceutical producers to deliver the highest quality products and services to network practitioners and their patients.
CONTACT: Elijah Johnson, Marketing Director, [email protected], (877) 846-9009
SOURCE BodyLogicMD
